Discovery & Development

Environmentally friendly catalyst technologies are on the rise in pharma.

What difference can taste-masking make to the patient experience?

In regenerative medicines and therapeutics, fibroblasts can offer significant advantages over stem cells, says Hamid Khoja

A new method for muting malaria turns one of the parasite’s proteins into a self-destruction device

The DNDi is doing incredible work across the world. In this digital feature, we explore a portion of these open science efforts.

This is the story of how DNDi put forward a new model for collaborative, open science.

What links the DNDi and one of Google’s most futuristic AI assets? We get the story from DeepMind’s protein premier.

Two friends, two countries; one disease, one network to fight it. We spoke to two leaders of DNDi’s Leishmaniasis East Africa Network.

How a scattershot lunar alliance launched a cybernetic rocket at SARS-CoV-2

How pharma is working to develop efficient and patient-centric trials.